Predictors of first repeat biopsy cancer detection with suspected local stage prostate cancer

Journal of Urology

Volumn 163, Issue 3, 2000, Pages 813-818

  Fowler Jr , Jackson E ^a   Bigler, Steven A ^a   Miles, Derek ^a   Yalkut, Denis A ^a  

^a UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

Author keywords

Biopsy; Prostate; Prostate specific antigen; Prostatic intraepithelial neoplasia; Prostatic neoplasms

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATECTOMY; RADIOIMMUNOASSAY;

EID: 0033952260     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(05)67810-X     Document Type: Article

References (38)

1. Catalona, W. J., Smith, D. S., Ratliff, T. L. et al: Measurement of prostate-specific antigen in serum as a screening test for prostate cancer. N Engl J Med, 324: 1156, 1991
2. Rommel, F. M., Agusta, V. E., Breslin, J. A. et al: The use of prostate specific antigen and prostate specific antigen density in the diagnosis of prostate cancer in a community based urology practice. J Urol, 151: 88, 1994
3. Hodge, K. K., McNeal, J. E., Terris, M. K. et al: Random systematic versus directed ultrasound guided transrectal core biopsies of the prostate. J Urol, 142: 71, 1989
4. Keetch, D. W., Catalona, W. J. and Smith, D. S.: Serial prostatic biopsies in men with persistently elevated serum prostate specific antigen values. J Urol, 151: 1571, 1994
5. Morgan, T. O., McLeod, D. G., Leifer, E. S. et al: Prospective use of free prostate-specific antigen to avoid repeat prostate biopsies in men with elevated total prostate-specific antigen. Urology, 48: 76, 1996
6. Catalona, W. J., Beiser, J. A. and Smith, D. S.: Serum free prostate specific antigen and prostate specific antigen density measurements for predicting cancer in men with prior negative prostatic biopsies. J Urol, 158: 2162, 1997
7. Ellis, W. J. and Brawer, M. K.: Repeat prostate needle biopsy: who needs it? J Urol, 153: 1496, 1995
8. Fleshner, N. E., O'Sullivan, M. and Fair, W. R.: Prevalence and predictors of a positive repeat transrectal ultrasound guided needle biopsy of the prostate. J Urol, 158: 505, 1997
9. Perachino, M., di Ciolo, L., Barbetti, V. et al: Results of rebiopsy for suspected prostate cancer in symptomatic men with elevated PSA levels. Eur Urol, 32: 155, 1997
10. Ukimura, O., Durrani, O. and Babaian, R. J.: Role of PSA and its indices in determining the need for repeat prostate biopsies. Urology, 50: 66, 1997
11. Keetch, D. W., McMurtry, J. M., Smith, D. S. et al: Prostate specific antigen density versus prostate specific antigen slope as predictors of prostate cancer in men with initially negative prostatic biopsies. J Urol, 156: 428, 1996
12. Rabbani, F., Stroumbakis, N., Kava, B. R. et al: Incidence and clinical significance of false-negative sextant prostate biopsies. J Urol, 159: 1247, 1998
13. Letran, J. L., Blase, A. B., Loberiza, F. R. et al: Repeat ultrasound guided prostate needle biopsy: use of free-to-total prostate specific antigen ratio in predicting prostatic carcinoma. J Urol, 160: 426, 1998
14. Raviv, G., Zlotta, A. R., Janssen, Th. et al: Do prostate specific antigen and prostate specific antigen density enhance the detection of prostate carcinoma after initial diagnosis of prostatic intraepithelial neoplasia without concurrent carcinoma? Cancer, 77: 2103, 1996
15. Shepherd, D., Keetch, D. W., Humphrey, P. A. et al: Repeat biopsy strategy in men with isolated prostatic intraepithelial neoplasia on prostate needle biopsy. J Urol, 156: 460, 1996
16. Oesterling, J. E., Jacobsen, S. J., Chute, C. G. et al.: Serum prostate-specific antigen in a community-based population of healthy men. Establishment of age-specific references ranges. JAMA, 270: 860, 1993
17. Beahrs, O. H., Henson, D., Hutter, R. V. P. et al: Manual for Staging of Cancer, 4th ed. Philadelphia: J. B. Lippincott, 1992
18. Terris, M. K., Pham, T. Q., Issa, M. M. et al: Routine transition zone and seminal vesicle biopsies in all patients undergoing transrectal ultrasound guided prostate biopsies are not indicated. J Urol, 157: 204, 1997
19. Eskew, L. A., Bare, R. L. and McCullough, D. L.: Systematic 5 region prostate biopsy is superior to sextant method for diagnosing carcinoma of the prostate. J Urol, 157: 199, 1997
20. Gleason, D. F.: Classification of prostatic carcinomas. Cancer Chemother Rep, 50: 125, 1966
21. Bostwick, D. G. and Brawer, M. K.: Prostatic intra-epithelial neoplasia and early invasion in prostate cancer. Cancer, 59: 788, 1987
22. Terris, M. K. and Stamey, T. A.: Determination of prostate volume by transrectal ultrasound. J Urol, 145: 984, 1991
23. Carter, H. B., Pearson, J. D., Waclawiw, Z. et al: Prostate-specific antigen variability in men without prostate cancer: Effect of sampling interval on prostate-specific antigen velocity. Urology, 45: 591, 1995
24. Yuan, J. J. J., Coplen, D. E., Petros, J. A. et al: Effects of rectal examination, prostatic massage, ultrasonography and needle biopsy on serum prostate specific antigen levels. J Urol, 147: 810, 1992
25. Catalona, W. J., Partin, A. W., Slawin, K. M. et al: Use of the percentage of free prostate-specific antigen to enhance differentiation of prostate cancer from benign prostatic disease: a prospective multicenter clinical trial. JAMA, 279: 1542, 1998
26. Catalona, W. J., Smith, D. S. and Ornstein, D. K.: Prostate cancer detection in men with serum PSA concentrations of 2.6 to 4.0 ng/ml and benign prostate examination. Enhancement of specificity with free PSA measurements. JAMA, 277: 1452, 1997
27. Brawer, M. K., Bigler, S. A., Sohlberg, O. E. et al: Significance of prostatic intraepithelial neoplasia on prostate needle biopsy. Urology, 38: 103, 1991
28. Bostwick, D. G., Qian, J. and Frankel, K: The incidence of high grade prostatic intraepithelial neoplasia in needle biopsies. J Urol, 154: 1791, 1995
29. Wills, M. L., Hamper, U. M., Partin, A. W. et al: Incidence of high-grade prostatic intraepithelial neoplasia in sextant needle biopsy specimens. Urology, 49: 367, 1997
30. Bigler, S. A., Fowler, J. E., Jr., Land, S. A. et al: High grade prostatic intraepithelial neoplasia (PIN) in Caucasians and African Americans. Lab Invest, 79: 90A, 1999
31. Prestigiacomo, A. F. and Stamey, T. A.: Physiological variation of serum prostate specific antigen in the 4.0 to 10.0 ng/ml range in male volunteers. J Urol, 155: 1977, 1996
32. Carter, H. B., Pearson, J. D., Metter, E. J. et al.: Longitudinal evaluation of prostate specific antigen levels in men with and without prostate disease. JAMA, 267: 2215, 1992
33. Sakr, W. A.: Prostatic intraepithelial neoplasia: a marker for high-risk groups and a potential target for chemoprevention. Eur Urol, 35: 474, 1999
34. Miller, B. A., Ries, L. A. G., Hankey, B. F. et al: SEER Cancer Statistics Review. 1973-1990. Bethesda, Maryland: National Cancer Institute. NIH Pub. No., 93-2789, 1993
35. Albertsen, P. C., Hanley, J. A., Gleason, D. F. et al: Competing risk analysis of men aged 55 to 74 years at diagnosis managed conservatively for clinically localized prostate cancer. JAMA, 280: 975, 1998
36. Pound, C. R., Partin, A. W., Epstein, J. I. et al: Prostate-specific antigen after anatomic radical retropubic prostatectomy. Patterns of recurrence and cancer control. Urol Clin North Am, 24: 395, 1997
37. Zagars, G. K., Pollack, A. and von Eschenbach, A. C.: Prognostic factors for clinically localized prostate carcinoma: analysis of 938 patients irradiated in the prostate specific antigen era. Cancer, 79: 1370, 1997
38. Fowler, J. E., Jr., Bigler, S. A. and Kolski, J. M.: Prostate cancer detection in candidates for open prostatectomy. J Urol, 160: 2107, 1998